This trial tests a new drug's safety, side effects, and how it's absorbed in healthy adults.
- Type 2 Diabetes
1 Primary · 3 Secondary · Reporting Duration: Day 1 to Day 3
4 Treatment Groups
Cohort 1 (healthy volunteers)
1 of 4
Cohort 3 (healthy Chinese volunteers)
1 of 4
Cohort 4 (healthy volunteers - food effect)
1 of 4
Cohort 2 (healthy Japanese volunteers)
1 of 4
72 Total Participants · 4 Treatment Groups
Primary Treatment: Cohort 1 (healthy volunteers) · Has Placebo Group · Phase 1
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Age 18 - 55 · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does this investigation extend to geriatric individuals?
"This trial has set the lower age limit for eligibility at 18 years old and capped off the maximum age requirement at 55." - Anonymous Online Contributor
What is the current enrollment capacity for this clinical trial?
"Correct. According to the information posted on clinicaltrials.gov, this medical study is accepting participants at present. This research was first made available on December 20th 2022 and the details were last updated on January 12th 2023. 72 people are needed for enrolment across 1 site location." - Anonymous Online Contributor
What risks do healthy volunteers face when joining Cohort 1?
"Due to the limited number of supporting data, Cohort 1 (healthy volunteers) are assessed as having a low safety rating – score one on our scale at Power. This is in line with Phase 1 trial standards." - Anonymous Online Contributor
Does this research initiative have any open positions?
"Affirmative. Clinicaltrials.gov provides evidence that this research effort, which was initially published on December 20th 2022, is currently recruiting participants. The trial requires 72 individuals to be enrolled from one site." - Anonymous Online Contributor
Am I eligible to partake in this investigation?
"This trial demands 72 participants, aged 18 to 55 years old who possess type 2 diabetes. Furthermore, all individuals must meet the following expectations: have provided signed and dated consent for this research; men or women of non-childbearing potential that weigh no less than 50 kgs and are within a BMI range from 18 - 32 inclusive; those partaking in Part Two need to be Japanese with both their parents and four grandparents being natively-born Japanese citizens, whereas Chinese subjects involved in Part Three require both of their parents and all 4 grandparents hailing from China (no more than 10 years spent abroad)." - Anonymous Online Contributor